2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications
DOI 10.1006/bbrc.1995.2437

Cited by (1,009)

Items 101–200 of 1,009

  1. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
    Takayuki Sugiura, Yuriko Kobayashi, Saori Oka, Keizo Waku · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  2. Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress
    Bortolato, Marco, Mangieri, Regina A., Fu, Jin, Kim, Janet H., Arguello, Oliver, Duranti, Andrea, Tontini, Andrea, Mor, Marco, Tarzia, Giorgio, Piomelli, Daniele · 2007 · Biological Psychiatry
  3. N-Oleoyldopamine, a Novel Endogenous Capsaicin-like Lipid That Produces Hyperalgesia
    Constance J. Chu, Susan M. Huang, Luciano De PETROCELLIS, Tiziana Bisogno, Scott A. Ewing, Jeffrey D. Miller, Robert E. Zipkin, Nives Daddario, Giovanni Appendino, Vincenzo Di Marzo et al. · 2003 · Journal of Biological Chemistry
  4. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1receptors on peripheral sympathetic nerves
    Edward J.N. Ishac, Liu Jiang, Kristy D. Lake, Károly Varga, Mary E. Abood, George Kunos · 1996 · British Journal of Pharmacology
  5. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis
    Matthew N. Hill, Jeffrey G. Tasker · 2011 · Neuroscience
  6. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens
    Basalingappa L. Hungund, Istvan Szakall, Ágota Ádám, Balapal S. Basavarajappa, Csaba Vadász · 2003 · Journal of Neurochemistry
  7. Cannabinoids and neuroinflammation
    Lisa Marie Walter, Nephi Stella · 2004 · British Journal of Pharmacology
  8. A new perspective on cannabinoid signalling: complimentary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain.
    Michaela Egertová, Dan K. Giang, Ben F. Cravatt, Maurice R. Elphick · 1998 · Proceedings of the Royal Society B Biological Sciences
  9. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
    Bossong, Matthijs G., Niesink, Raymond J.M. · 2010 · Progress in Neurobiology
  10. Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand
    Sravan Kumar Goparaju, Natsuo Ueda, Hiroko Yamaguchi, Shozo Yamamoto · 1998 · FEBS Letters
  11. Localization of Diacylglycerol Lipase-α around Postsynaptic Spine Suggests Close Proximity between Production Site of an Endocannabinoid, 2-Arachidonoyl-glycerol, and Presynaptic Cannabinoid CB1 Receptor
    Takayuki Yoshida, Masahiro Fukaya, Motokazu Uchigashima, Eriko Miura, Haruyuki Kamiya, Masanobu Kano, Masahiko Watanabe · 2006 · Journal of Neuroscience
  12. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
    Anthony P. Davenport, S P H Alexander, Joanna L Sharman, Adam J Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig et al. · 2013 · Pharmacological Reviews
  13. Activity-based Proteomics of Enzyme Superfamilies: Serine Hydrolases as a Case Study
    Gabriel M. Simon, Benjamin F. Cravatt · 2010 · Journal of Biological Chemistry
  14. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine
    Artmann, Andreas, Petersen, Gitte, Hellgren, Lars I., Boberg, Julie, Skonberg, Christian, Nellemann, Christine, Hansen, Steen Honoré, Hansen, Harald S. · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  15. Functional CB1 cannabinoid receptors in human vascular endothelial cells
    Jie Liu, Bin Gao, Faridoddin Mirshahi, Arun Jayant Sanyal, Atmaram D. Khanolkar, Alexandros Makriyannis, George Kunos · 2000 · Biochemical Journal
  16. Cannabis, the mind and society: the hash realities
    Robin M. Murray, Paul D. Morrison, Cécile Henquet, Marta Di Forti · 2007 · Nature reviews. Neuroscience
  17. DAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling
    Thomas Oliver Eichmann, Achim Lass · 2015 · Cellular and Molecular Life Sciences
  18. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond
    Roger G. Pertwee · 2008 · Addiction Biology
  19. Endogenous cannabinoid system as a modulator of food intake
    Daniela Cota, Giovanni Marsicano, Beat Lutz, Valentina Vicennati, Günter Karl Stalla, Riccardo Pasquali, Uberto Pagotto · 2003 · International Journal of Obesity
  20. Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal
    Yuki Hashimotodani, Takako Ohno‐Shosaku, Hiroshi Tsubokawa, Hidenori Ogata, Ken Emoto, Takashi Maejima, Kenji Araishi, Hee‐Sup Shin, Masanobu Kano · 2005 · Neuron
  21. ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance
    Vincenzo Di Marzo · 1998 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
  22. Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function
    Tiziana Bisogno, Fernando Berrendero, Gerolmina Ambrosino, Maribel Cebeira, José Antonio Ramos, Javier Fernández‐Ruíz, Vincenzo Di Marzo · 1999 · Biochemical and Biophysical Research Communications
  23. Phytocannabinoids as novel therapeutic agents in {CNS} disorders.
    Hill, Andrew J., Williams, Claire M., Whalley, Benjamin J., Stephens, Gary J. · 2012 · Pharmacology & Therapeutics
  24. Endocannabinoids: synthesis and degradation
    Vincenzo Di Marzo · 2006 · Reviews of physiology, biochemistry and pharmacology
  25. Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor
    Takayuki Sugiura, Tomoko Kodaka, Shinji Nakane, Tomoyuki Miyashita, Sachiko Kondo, Yoshitomo Suhara, Hiroaki Takayama, Keizo Waku, Chiyo Seki, Naomichi Baba et al. · 1999 · Journal of Biological Chemistry
  26. Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
    Rahn, Elizabeth J., Hohmann, Andrea G. · 2009 · Neurotherapeutics
  27. Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism
    Jonathan Z. Long, Daniel K. Nomura, Benjamin F. Cravatt · 2009 · Chemistry & Biology
  28. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
    Vincenzo Di Marzo, Michael P. Hill, Tiziana Bisogno, Alan R. Crossman, Jonathan M. Brotchie · 2000 · The FASEB Journal
  29. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
    Richardson, Denise, Pearson, Richard G, Kurian, Nisha, Latif, M Liaque, Garle, Michael J, Barrett, David A, Kendall, David A, Scammell, Brigitte E, Reeve, Alison J, Chapman, Victoria · 2008 · Arthritis Research & Therapy
  30. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
    Benjamin F. Cravatt, Aron H. Lichtman · 2003 · Current Opinion in Chemical Biology
  31. Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
    Carol A. Rouzer, Lawrence J. Marnett · 2011 · Chemical Reviews
  32. Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses
    Takako Ohno‐Shosaku, Hiroshi Tsubokawa, Ichiro Mizushima, Norihide Yoneda, Andreas Zimmer, Masanobu Kano · 2002 · Journal of Neuroscience
  33. The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain
    Donvito, Giulia, Nass, Sara R, Wilkerson, Jenny L, Curry, Zachary A, Schurman, Lesley D, Kinsey, Steven G, Lichtman, Aron H · 2018 · Neuropsychopharmacology
  34. 2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans
    Katrine Bagge Hansen, METTE MARIE ROSENKILDE, Filip Krag Knop, Niels Wellner, Thi Ai Diep, Jens Frederik Rehfeld, Ulrik Bjørn Andersen, Jens Juul Holst, Harald Severin Hansen · 2011 · The Journal of Clinical Endocrinology & Metabolism
  35. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
    Lichtman, Aron H, Shelton, Christopher C, Advani, Tushar, Cravatt, Benjamin F · 2004 · Pain
  36. Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages
    Vincenzo Di Marzo, Tiziana Bisogno, Luciano De PETROCELLIS, Dominique J. Melck, Pierangelo Orlando, Jens A. Wagner, George Kunos · 1999 · European Journal of Biochemistry
  37. Why do cannabinoid receptors have more than one endogenous ligand?
    Di Marzo, Vincenzo, De Petrocellis, Luciano · 2012 · Philosophical Transactions of the Royal Society B: Biological Sciences
  38. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain
    Hermann, H, Marsicano, G, Lutz, B · 2002 · Neuroscience
  39. Dietary fatty acids ? The n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan
    Harumi Okuyama · 1996 · Progress in Lipid Research
  40. Cannabinoids and Cytochrome P450 Interactions
    Ondřej Zendulka, Gabriela Dovrtělová, Kristýna Nosková, Miroslav Turjap, Alexandra Šulcová, Lumír Hanuš, Jan Juřica · 2016 · Current Drug Metabolism
  41. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
    Mario van der Stelt, Vincenzo Di Marzo · 2003 · European Journal of Pharmacology
  42. Afferents from rat temporal cortex synapse on lateral amygdala neurons that express NMDA and AMPA receptors
    Claudia R. Farb, Joseph E. LeDoux · 1999 · Synapse
  43. Endocannabinoids and the regulation of their levels in health and disease
    Vincenzo Di Marzo, Stefania Petrosino · 2007 · Current Opinion in Lipidology
  44. Possible endocannabinoid control of colorectal cancer growth
    Alessia Ligresti, Tiziana Bisogno, Isabel Matias, Luciano De PETROCELLIS, Maria Grazia Cascio, Vittorio Cosenza, Giuseppe D’Argenio, Giuseppe Scaglione, Maurizio Bifulco, Italo Sorrentini et al. · 2003 · Gastroenterology
  45. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
    Jayamanne, Angelo, Greenwood, Ruth, Mitchell, Vanessa A, Aslan, Sevda, Piomelli, Daniele, Vaughan, Christopher W · 2006 · British Journal of Pharmacology
  46. A historical overview of chemical research on cannabinoids
    Raphael Mechoulam, Lumı́r Hanuš · 2000 · Chemistry and Physics of Lipids
  47. Rapid Glucocorticoid-Mediated Endocannabinoid Release and Opposing Regulation of Glutamate and γ-Aminobutyric Acid Inputs to Hypothalamic Magnocellular Neurons
    Shi Di, Renato Malcher‐Lopes, Victor L. Marcheselli, Nicolas Guillermo Bazan, Jeffrey G. Tasker · 2005 · Endocrinology
  48. Cannabinoid receptors and the regulation of immune response
    Evgueni V. Berdyshev · 2000 · Chemistry and Physics of Lipids
  49. Cannabinoids and Epilepsy
    Evan C. Rosenberg, Richard W. Tsien, Benjamin J. Whalley, Orrin Devinsky · 2015 · Neurotherapeutics
  50. Cannabinoid Receptors and Endocannabinoids: Evidence for New Players
    Ken Mackie, Nephi Stella · 2006 · The AAPS Journal
  51. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells
    Tiziana Bisogno, Nunzio Sepe, Dominique J. Melck, Stefano Maurelli, Luciano De PETROCELLIS, Vincenzo Di Marzo · 1997 · Biochemical Journal
  52. Endocannabinoid signaling in microglial cells
    Nephi Stella · 2008 · Neuropharmacology
  53. Structural determinants for recognition and translocation by the anandamide transporter
    Daniele Piomelli, Massimiliano Beltramo, S. Glasnapp, S. Lin, Andreas Goutopoulos, Xiang‐Qun Xie, Alexandros Makriyannis · 1999 · Proceedings of the National Academy of Sciences
  54. Supply and demand for endocannabinoids
    Bradley E. Alger, Jimok Kim · 2011 · Trends in Neurosciences
  55. Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
    Abir T. El‐Alfy, Kelly Ivey, Keisha Robinson, Safwat A. Ahmed, Mohamed M. Radwan, Desmond Slade, Ikhlas Ahmed Khan, Mahmoud A. ElSohly, Samir Anis Ross · 2010 · Pharmacology Biochemistry and Behavior
  56. Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms
    Atsushi Yamashita, Yasuhiro Hayashi, Yoko Nemoto‐Sasaki, Makoto Ito, Saori Oka, Takashi Tanikawa, Keizo Waku, Takayuki Sugiura · 2013 · Progress in Lipid Research
  57. Anticancer Mechanisms of Cannabinoids
    Guillermo Velasco, Cristina Sánchez, Manuel Guzmán · 2016 · Current Oncology
  58. Endocannabinoid‐mediated short‐term synaptic plasticity: depolarization‐induced suppression of inhibition (DSI) and depolarization‐induced suppression of excitation (DSE)
    Marco A. Diana, Alain Marty · 2004 · British Journal of Pharmacology
  59. Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation
    Dominique J. Melck, Luciano De PETROCELLIS, Pierangelo Orlando, Tiziana Bisogno, Chiara Laezza, Maurizio Bifulco, Vincenzo Di Marzo · 2000 · Endocrinology
  60. Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing
    Karen L. Wright, N ROONEY, Mark Feeney, J J T Tate, Duncan A. Robertson, Melanie J. Welham, Stephen Geoffrey Ward · 2005 · Gastroenterology
  61. The fatty acid amide hydrolase (FAAH)
    Natsuo Ueda, Robyn A. Puffenbarger, Shozo Yamamoto, Dale G. Deutsch · 2000 · Chemistry and Physics of Lipids
  62. Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
    Jens A. Wagner, Károly Varga, Zoltán Járai, George Kunos · 1999 · Hypertension
  63. Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output
    Hill, Matthew N., Patel, Sachin, Campolongo, Patrizia, Tasker, Jeffrey G., Wotjak, Carsten T., Bains, Jaideep S. · 2010 · The Journal of Neuroscience
  64. Cannabinoid CB1‐receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
    Angelo Antonio Izzo, Filomena Fezza, Raffaele Capasso, Tiziana Bisogno, Luísa Pinto, Teresa Iuvone, Giuseppe Esposito, Nicola Mascolo, Vincenzo Di Marzo, Francesco Capasso · 2001 · British Journal of Pharmacology
  65. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
    L. A. Smith, Fredric Azariah, Verna Lavender, Nicola S Stoner, Silvana S. Bettiol · 2015 · Cochrane Database of Systematic Reviews
  66. Cannabinoid Transmission and Reward-Related Events
    Eliot L. Gardner, Stanislav R. Vorel · 1998 · Neurobiology of Disease
  67. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
    David P. Finn, Simon Haroutounian, Andrea G. Hohmann, Elliot J. Krane, Nadia Soliman, Andrew S.C. Rice · 2021 · Pain
  68. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
    Cecilia J. Hillard · 2000 · Prostaglandins & Other Lipid Mediators
  69. Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons
    Miriam Melis, Simona Perra, Anna Lisa Muntoni, Giuliano Pillolla, Beat Lutz, Giovanni Marsicano, Vincenzo Di Marzo, Gian Luigi Gessa, Marco Pistis · 2004 · Journal of Neuroscience
  70. An introduction to the endocannabinoid system: from the early to the latest concepts
    Luciano De PETROCELLIS, Vincenzo Di Marzo · 2009 · Best Practice & Research Clinical Endocrinology & Metabolism
  71. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
    Hill, Matthew N., Carrier, Erica J., McLaughlin, Ryan J., Morrish, Anna C., Meier, Sarah E., Hillard, Cecilia J., Gorzalka, Boris B. · 2008 · Journal of Neurochemistry
  72. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N -acylethanolamines in piglets
    Alvin Berger, Gayle L. Crozier, Tiziana Bisogno · 2001 · Proceedings of the National Academy of Sciences
  73. Presynaptic Modulation by Endocannabinoids
    David M. Lovinger · 2007 · Handbook of experimental pharmacology
  74. The endocannabinoid system in brain reward processes
    Marcello Solinas, Steven R. Goldberg, Daniele Piomelli · 2008 · British Journal of Pharmacology
  75. Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
    Barbara Batetta, Mikko Griinari, Gianfranca Carta, Elisabetta Murru, Alessia Ligresti, Lina Cordeddu, Elena Giordano, Francesca Sanna, Tiziana Bisogno, Sabrina Uda et al. · 2009 · Journal of Nutrition
  76. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites
    Caroline Turcotte, Francois Chouinard, Julie S. Lefebvre, Nicolas Flamand · 2015 · Journal of Leukocyte Biology
  77. Anandamide receptors
    Vincenzo Di Marzo, Luciano De PETROCELLIS, Filomena Fezza, Alessia Ligresti, Tiziana Bisogno · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  78. GPR55: a new member of the cannabinoid receptor clan?
    Roger G. Pertwee · 2007 · British Journal of Pharmacology
  79. Actions of Cannabinoids on Membrane Properties and Synaptic Transmission in Rat Periaqueductal Gray Neurons In Vitro
    Christopher Walter Vaughan, Mark A. Connor, Elena E. Bagley, MacDonald J. Christie · 2000 · Molecular Pharmacology
  80. Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
    Raymond J.M. Niesink, Margriet van Laar · 2013 · Frontiers in Psychiatry
  81. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder
    Matthew N. Hill, Patrizia Campolongo, Rachel Yehuda, Sachin Patel · 2017 · Neuropsychopharmacology
  82. Molecular Pharmacology of Phytocannabinoids
    Sarah E. Turner, Claire Michelle Williams, Leslie Lars Iversen, Benjamin J. Whalley · 2017 · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products
  83. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
    Douglas Lee Boggs, Jacques D. Nguyen, Daralyn Morgenson, Michael A. Taffe, Mohini Ranganathan · 2017 · Neuropsychopharmacology
  84. Receptor-dependent formation of endogenous cannabinoids in cortical neurons
    Nephi Stella, Daniele Piomelli · 2001 · European Journal of Pharmacology
  85. Receptors for acylethanolamides—GPR55 and GPR119
    Grzegorz Godlewski, László Offertáler, Jens A. Wagner, George Kunos · 2009 · Prostaglandins & Other Lipid Mediators
  86. Neuroprotective Strategies in Parkinson???s Disease
    Silvia A. Mandel, Edna Grünblatt, Peter Franz Riederer, Manfred Gerlach, Yona Levites, Moussa B. H. Youdim · 2003 · CNS Drugs
  87. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids
    Hill, Matthew N., McEwen, Bruce S. · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  88. Metabolism of endocannabinoids and related N ‐acylethanolamines: Canonical and alternative pathways
    Natsuo Ueda, Kazuhito Tsuboi, Toru Uyama · 2013 · FEBS Journal
  89. 2-Arachidonoylglycerol and the cannabinoid receptors
    Takayuki Sugiura, Keizo Waku · 2000 · Chemistry and Physics of Lipids
  90. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice
    Rademacher, David J., Meier, Sarah E., Shi, Leyu, Vanessa Ho, W.-S., Jarrahian, Abbas, Hillard, Cecilia J. · 2008 · Neuropharmacology
  91. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172
    Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., Piomelli, D. · 2004 · Proceedings of the National Academy of Sciences
  92. Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility
    Haibin Wang, Sudhansu K. Dey, Mauro Maccarrone · 2006 · Endocrine Reviews
  93. The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
    David Panikashvili, Na’ama A. Shein, Raphael Mechoulam, Victoria Trembovler, Ron Kohen, Alexander G. Alexandrovich, Esther Shohami · 2005 · Neurobiology of Disease
  94. Endocannabinoids and immune regulation☆
    Rupal Pandey, Khalida M. Mousawy, Mitzi Nagarkatti, Prakash S. Nagarkatti · 2009 · Pharmacological Research
  95. Cellular signal transduction by anandamide and 2-arachidonoylglycerol
    A­llyn C. Howlett, Somnath Mukhopadhyay · 2000 · Chemistry and Physics of Lipids
  96. Synaptically Driven Endocannabinoid Release Requires Ca2+-Assisted Metabotropic Glutamate Receptor Subtype 1 to Phospholipase C β4 Signaling Cascade in the Cerebellum
    Takashi Maejima, Saori Oka, Yuki Hashimotodani, Takako Ohno‐Shosaku, Atsu Aiba, Dianqing Wu, Keizo Waku, Takayuki Sugiura, Masanobu Kano · 2005 · Journal of Neuroscience
  97. Cannabinoids and brain injury: therapeutic implications
    Rafael Mechoulam · 2002 · Trends in Molecular Medicine
  98. Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo
    Aron H. Lichtman, Edward G. Hawkins, Graeme Griffin, Benjamin F. Cravatt · 2002 · Journal of Pharmacology and Experimental Therapeutics
  99. Cannabinoids and Cannabinoid Receptors: The Story so Far
    Fred Shahbazi, Victoria Grandi, Abhinandan Banerjee, John Frederick Trant · 2020 · iScience
  100. Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims
    Basalingappa L. Hungund, K Y Vinod, Suham A. Kassir, Balapal S. Basavarajappa, Ratnakumar Yalamanchili, Thomas B. Cooper, J. John Mann, Victoria Arango · 2004 · Molecular Psychiatry